International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery
Hormone Research in Paediatrics · 10.12.2024 · 97 (6) · 636-662
DOI: 10.1159/000543034 ↗Kurz gefasst
Leitlinie in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 10.12.2024. Verfasst von Torben Biester und 10 weiteren Autor:innen. Beteiligte Einrichtung: AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany. Hauptthemen laut MEDLINE: Insulin, Insulin Infusion Systems, Diabetes Mellitus, Type 1, Hypoglycemic Agents. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind insulin administration, with special emphasis on insulin pump therapy, especially on glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
- Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
- Department of Pediatrics, Division of Pediatric Endocrinology, Santa Casa of São Paulo School of Medical Sciences, São Paulo, Brazil.
- Division of Endocrinology, Department of Pediatric, University of California San Francisco, San Francisco, California, USA.
- Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Biester, T., Berget, C., Boughton, C., Cudizio, L., Ekhlaspour, L., Hilliard, M. E., Reddy, L., Sap Ngo Um, S., Schoelwer, M., Sherr, J. L., & Dovc, K. (2024). International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery. Hormone Research in Paediatrics, 97(6), 636-662. https://doi.org/10.1159/000543034
Vancouver
Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard ME, et al. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery. Hormone Research in Paediatrics. 2024;97(6):636-662. doi:10.1159/000543034
BibTeX
@article{Biester2024,
author = {Biester, Torben and Berget, Cari and Boughton, Charlotte and Cudizio, Laura and Ekhlaspour, Laya and Hilliard, Marisa E and Reddy, Leenatha and Sap Ngo Um, Suzanne and Schoelwer, Melissa and Sherr, Jennifer L and Dovc, Klemen},
title = {International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery},
journal = {Hormone Research in Paediatrics},
year = {2024},
volume = {97},
number = {6},
pages = {636--662},
doi = {10.1159/000543034}
}
EUVIMED